Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2014, Article ID 919256, 7 pages
Review Article

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

Second Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan

Received 26 November 2013; Accepted 23 December 2013; Published 30 January 2014

Academic Editor: Kazushi Tsuda

Copyright © 2014 Hirofumi Tomiyama and Akira Yamashina. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Diego Lezama-Martínez, Ignacio Valencia-Hernández, Jazmin Flores-Monroy, and Luisa Martínez-Aguilar, “Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.,” Dose-response : a publication of International Hormesis Society, vol. 15, no. 4, pp. 1559325817737932, . View at Publisher · View at Google Scholar
  • Ya-Juan Wang, Bamidele O. Tayo, Anupam Bandyopadhyay, Heming Wang, Tao Feng, Nora Franceschini, Hua Tang, Jianmin Gao, Yun Ju Sung, Robert C. Elston, Scott M. Williams, Richard S. Cooper, Ting-Wei Mu, and Xiaofeng Zhu, “The Association of the Vanin-1 N131S Variant with Blood Pressure Is Mediated by Endoplasmic Reticulum-Associated Degradation and Loss of Function,” Plos Genetics, vol. 10, no. 9, 2014. View at Publisher · View at Google Scholar
  • Ashim Malhotra, Parmbir Kahlon, Ian C. Doyle, and Timothy Donoho, “Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth syndrome,” Recent Patents on Biotechnology, vol. 8, no. 2, pp. 136–143, 2014. View at Publisher · View at Google Scholar
  • Richard Gargiulo, Faten Suhail, and Edgar Lerma, “Hypertension and chronic kidney disease,” Disease-a-Month, 2015. View at Publisher · View at Google Scholar
  • Iyngkaran, and Thomas, “Bedside–to-bench translational research for chronic heart failure: Creating an agenda for clients who do not meet trial enrollment criteria,” Clinical Medicine Insights: Cardiology, vol. 9, pp. 121–132, 2015. View at Publisher · View at Google Scholar
  • Alfonso H Santos, Michael J. Casey, Charles M. Bucci, Shehzad Rehman, and Mark S. Segal, “Nebivolol Effects on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients,” The Journal of Clinical Hypertension, 2015. View at Publisher · View at Google Scholar
  • Michael E. Hall, Michael V. Rocco, Timothy M. Morgan, Craig A. Hamilton, Jennifer H. Jordan, Matthew S. Edwards, John E. Hall, and William G. Hundley, “Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis,” CardioRenal Medicine, vol. 6, no. 4, pp. 261–268, 2016. View at Publisher · View at Google Scholar
  • Bw Teo, Hr Chua, Wk Wong, S Haroon, S Subramanian, Pt Loh, S Sethi, and T Lau, “Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients,” Singapore Medical Journal, vol. 57, no. 05, pp. 267–273, 2016. View at Publisher · View at Google Scholar
  • Fateme Shamekhi Amiri, “Recent advances in the treatment of renal diseases with nebivolol: A literature review,” Néphrologie & Thérapeutique, 2016. View at Publisher · View at Google Scholar
  • Nasimudeen R. Jabir, Ali Nasir Siddiqui, Chelapram Kandy Firoz, Ghulam Md Ashraf, Syed Kashif Zaidi, Mohd Shahnawaz Khan, Shazi Shakil, Mohammed Nabil Alama, Mohammad Amjad Kamal, and Shams Tabrez, “Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases,” Current Pharmaceutical Design, vol. 22, no. 5, pp. 566–571, 2016. View at Publisher · View at Google Scholar
  • Mikail Yarlioglues, “Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease,” Resistant Hypertension in Chronic Kidney Disease, pp. 219–231, 2017. View at Publisher · View at Google Scholar
  • Seungkirl Ahn, Alem W. Kahsai, Biswaranjan Pani, Qin-Ting Wang, Shuai Zhao, Alissa L. Wall, Ryan T. Strachan, Dean P. Staus, Laura M. Wingler, Lillian D. Sun, Justine Sinnaeve, Minjung Choi, Ted Cho, Thomas T. Xu, Gwenn M. Hansen, Michael B. Burnett, Jane E. Lamerdin, Daniel L. Bassoni, Bryant J. Gavino, Gitte Husemoen, Eva K. Olsen, Thomas Franch, Stefano Costanzi, Xin Chen, and Robert J. Lefkowitz, “Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library,” Proceedings of the National Academy of Sciences, pp. 201620645, 2017. View at Publisher · View at Google Scholar
  • Kim Marienhagen, Frank Lehner, Jürgen Klempnauer, Hartmut Hecker, and Jürgen Borlak, “Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications,” Vascular Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Hsing-Chen Wu, Shou-Cheng Hsu, Yi-Jen Tsai, Jo-Hua Chiang, Jai-Sing Yang, Shih-Chang Tsai, You-Li Lee, Fuu-Jen Tsai, Daih-Huang Kuo, and Chi-Ting Horng, “Relaxant and vasoprotective effects of ginger extracts on porcine coronary arteries,” International Journal of Molecular Medicine, vol. 41, no. 4, pp. 2420–2428, 2018. View at Publisher · View at Google Scholar
  • Kaicheng Meng, Paul Shim, Qingtin Wang, Shuai Zhao, Ting Gu, Alem W. Kahsai, Seungkirl Ahn, and Xin Chen, “Design, synthesis and functional assessment of Cmpd-15 derivatives as negative allosteric modulators for the β 2 -adrenergic receptor,” Bioorganic & Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • Jihee Kim, Chad A. Grotegut, James W. Wisler, Tianyu Li, Lan Mao, Minyong Chen, Wei Chen, Paul B. Rosenberg, Howard A. Rockman, and Robert J. Lefkowitz, “β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility,” Skeletal Muscle, vol. 8, no. 1, 2018. View at Publisher · View at Google Scholar